Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene
Bibliographic Data
| ID | 14908102 |
|---|---|
| Authors | Jack Gunn (0000-0003-2867-6689, Burnet Institute, corresponding author), Stephen McNally (0000-0002-6455-1368), JOHN RYAN (0000-0002-9203-5512), Chloe Layton (Burnet Institute), Mellissa Bryant (Burnet Institute), Shelley Walker (0000-0003-4355-1956, Burnet Institute), Crios O'Mahony, Alisa Pedrana (0000-0002-1998-5722, Burnet Institute) |
| Year | 2021 |
| Volume | 96 |
| Pages | 103387 |
| Publication date | 2021-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2021.103387 |
| PMID | 34330571 |
| OpenAlex | W3185922023 |
| Language | EN |
| Citations received | 6 |
| References cited | 25 |
Family medicine · Harm reduction · Hepatitis C · Human immunodeficiency virus (HIV · Medical education · Medical emergency · Psychiatry · Syringe · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Nursing · Psychology · Virology
Injection drug use in an affluent beachside community in Sydney
It’s Your Right – implementation and outcomes of a co-designed national Australian hepatitis C health promotion campaign
Radical hospitality
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs
Financial incentives to increase engagement across the hepatitis C care cascade among people at risk of or diagnosed with hepatitis C
Barriers and facilitators to implementing a Pharmacist, Physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Understanding Barriers to Hepatitis C Virus Care and Stigmatization From a Social Perspective
Point-of-care hepatitis C testing from needle and syringe programs
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Conceptualising access in the direct-acting antiviral era
Using thematic analysis in psychology
| Unique citing works | 6 |
|---|---|
| Citations per year | 1,2 |
| Citation span | 2021 - 2026 (6) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 6 |